CLCM
XERS icon

Crawford Lake Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Crawford Lake Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-72,493
Closed -$4.16M – 80
2019
Q4 		$4.16M Buy
+72,493
New +$599K 0.63% 42

Other funds holding XERS

Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Sessa Capital
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Redmile Group
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HP
Hound Partners New York $863M AUM 11.22% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Crawford Lake Capital Management's XERS Position: Q1 2020 in Review

Crawford Lake Capital Management sold out of Xeris Biopharma Holdings (XERS) in Q1 2020, closing a stake of 72,493 shares — an estimated $4.16M sold.

Crawford Lake Capital Management first reported a position in XERS in Q4 2019 and held it in 1 quarter. The position peaked at $4.16M in Q4 2019. 67 funds tracked by Wall St. Rank hold XERS as of Q1 2020.

  • Crawford Lake Capital Management reported no remaining Xeris Biopharma Holdings position as of Q1 2020 after selling out during the quarter.
  • Crawford Lake Capital Management sold 72,493 Xeris Biopharma Holdings shares in Q1 2020, an estimated $4.16M.
  • Crawford Lake Capital Management first reported a position in Xeris Biopharma Holdings in Q4 2019 and held it in 1 quarter.
  • Crawford Lake Capital Management's Xeris Biopharma Holdings position peaked at $4.16M in Q4 2019.
  • 67 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2020.

Based on Crawford Lake Capital Management's 13F filing for Q1 2020, filed 15 May 2020.